Comparison of information-dependent acquisition on a tandem quadrupole TOF vs a triple quadrupole linear ion trap mass spectrometer for broad-spectrum drug screening

Clinical Chemistry

Volumn 62, Issue 1, 2016, Pages 170-178

  Thoren, Katie L ^a   Colby, Jennifer M ^b   Shugarts, Sarah B ^c   Wu, Alan H B ^b   Lynch, Kara L ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CLONAZEPAM; CODEINE; CYCLOBENZAPRINE; DESIPRAMINE; DEXTROMETHORPHAN; DIAZEPAM; DIHYDROCODEINE; DIPHENHYDRAMINE; DOXEPIN; DOXYLAMINE; EPHEDRINE; FENTANYL; GABAPENTIN; HALOPERIDOL; HYDROCODONE; HYDROMORPHONE; IMIPRAMINE; LAMOTRIGINE; LEVAMISOLE; LIDOCAINE; LORAZEPAM; LOXAPINE; METHAMPHETAMINE; METHYLPHENIDATE; MIDAZOLAM; MIRTAZAPINE; MORPHINE; DRUG;

ARTICLE; CHROMATOGRAPHY; DRUG SCREENING; HUMAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETER; TANDEM MASS SPECTROMETRY; TANDEM QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETER; TRIPLE QUADRUPOLE LINEAR ION TRAP MASS SPECTROMETER; URINALYSIS; COMPARATIVE STUDY; PRECLINICAL STUDY; URINE;

CHROMATOGRAPHY, LIQUID; DRUG EVALUATION, PRECLINICAL; HUMANS; PHARMACEUTICAL PREPARATIONS; TANDEM MASS SPECTROMETRY;

EID: 84954511823     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2015.241315     Document Type: Article

References (31)

1. Ojanperä I, Kolmonen M, Pelander A. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Anal Bioanal Chem 2012;403:1203-20.
2. Krauss M, Singer H, Hollender J. LC-high resolutionMS in environmental analysis: from target screening to the identification of unknowns. Anal Bioanal Chem 2010;397:943-51.
3. Wu AH, Gerona R, Armenian P, French D, Petrie M, Lynch KL. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology. Clin Toxicol (Phila) 2012;50:733-42.
4. Herrero P, Cortés-Francisco N, Borrull F, Caixach J, Pocurull E, Marcé RM. Comparison of triple quadrupole mass spectrometry and Orbitrap high-resolution mass spectrometry in ultrahigh performance liquid chromatography for the determination of veterinary drugs in sewage: benefits and drawbacks. J Mass Spectrom 2014;49:585-96.
5. Crews BO, Pesce AJ, West R, Nguyen H, Fitzgerald RL. Evaluation of high-resolution mass spectrometry for urine toxicology screening in a pain management setting. J Anal Toxicol 2012;36:601-7.
6. Hamelin EI, Bragg W, Shaner RL, Swaim LL, Johnson RC. Comparison of high-resolution and tandem mass spectrometry for the analysis of nerve agent metabolites in urine. Rapid Commun Mass Spectrom 2013;27:1697-704.
7. Rosano TG, Na S, Ihenetu K, Swift TA, Wood M. Multidrug and metabolite quantification in postmortem blood by liquid chromatography-high-resolution mass spectrometry: comparison with nominal mass technology. J Anal Toxicol 2014;38:495-506.
8. Kaufmann A, Butcher P, Maden K, Walker S, Widmer M. Quantitative and confirmative performance of liquid chromatography coupled to high-resolution mass spectrometry compared to tandem mass spectrometry. Rapid Commun Mass Spectrom 2011;25:979-92.
9. Pozo OJ, Van Eenoo P, Deventer K, Elbardissy H, Grimalt S, Sancho JV, et al. Comparison between triple quadrupole, time of flight and hybrid quadrupole time of flight analysers coupled to liquid chromatography for the detection of anabolic steroids in doping control analysis. Anal Chim Acta 2011;684:107-20.
10. Chindarkar NS, Wakefield MR, Stone JA, Fitzgerald RL. Liquid chromatography high-resolution TOF analysis: investigation of MSE for broad-spectrum drug screening. Clin Chem 2014;60:1115-25.
11. Wang J, Leung D. Analyses of macrolide antibiotic residues in eggs, raw milk, and honey using both ultraperformance liquid chromatography/quadrupole timeofflight mass spectrometry and high-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2007;21:3213-22.
12. Dresen S, Ferreirós N, Gnann H, Zimmermann R, Weinmann W. Detection and identification of 700 drugs by multi-target screening with a 3200 Q TRAP LC-MS/MS system and library searching. Anal Bioanal Chem 2010;396:2425-34.
13. Wohlfarth A, Scheidweiler KB, Chen X, Liu H-F, Huestis MA. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search. Anal Chem 2013;85:3730-8.
14. Mueller CA, Weinmann W, Dresen S, Schreiber A, Gergov M. Development of a multi-target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid Commun Mass Spectrom 2005;19:1332-8.
15. Sauvage FL, Saint-Marcoux F, Duretz B, Deporte D, Lachatre G, Marquet P. Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry. Clin Chem 2006;52:1735-42.
16. Marquet P, Saint-Marcoux F, Gamble TN, Le Blanc JCY. Comparison of a preliminary procedure for the general unknown screening of drugs and toxic compounds using a quadrupole-linear ion-trap mass spectrometer with a liquid chromatography-mass spectrometry reference technique. J Chromatogr B Analyt Technol Biomed Life Sci 2003;789:9-18.
17. Lynch KL, Breaud AR, Vandenberghe H, Wu AHB, Clarke W. Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening. Clin Chim Acta 2010;411:1474-81.
18. Herrin GL, McCurdy HH, Wall WH. Investigation of an LC-MS-MS (QTrap) method for the rapid screening and identification of drugs in postmortem toxicology whole blood samples. J Anal Toxicol 2005;29:599-606.
19. Liu H-C, Liu RH, Ho H-O, Lin D-L. Development of an information-rich LC-MS/MS database for the analysis of drugs in postmortem specimens. Anal Chem 2009;81:9002-11.
20. Liu Y, Uboh CE, Soma LR, Li X, Guan F, You Y, et al. Efficient use of retention time for the analysis of 302 drugs in equine plasma by liquid chromatography-MS/MS with scheduled multiple reaction monitoring and instant library searching for doping control. Anal Chem 2011;83:6834-41.
21. Broecker S, Herre S, Wüst B, Zweigenbaum J, Pragst F. Development and practical application of a library of CID accurate mass spectra of more than 2, 500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition. Anal Bioanal Chem 2010;400:101-17.
22. Broecker S, Herre S, Pragst F. General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). Forensic Sci Int 2012;218:68-81.
23. Pavlic M, Libiseller K, Oberacher H. Combined use of ESI-QqTOF-MS and ESI-QqTOF-MS/MS with massspectral library search for qualitative analysis of drugs. Anal Bioanal Chem 2006;386:69-82.
24. Decaestecker TN, Casteele SRV, Wallemacq PE, Van Peteghem CH, Defore DL, Van Bocxlaer JF. Informationdependent acquisition-mediated LC-MS/MS screening procedure with semiquantitative potential. Anal Chem 2004;76:6365-73.
25. Broecker S, Pragst F, Bakdash A, Herre S, Tsokos M. Combined use of liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) and high performance liquid chromatography with photodiode array detector (HPLC-DAD) in systematic toxicological analysis. Forensic Sci Int 2011;212:215-26.
26. González-Mariño I, Quintana JB, Rodríguez I, González-Díez M, Cela R. Screening and selective quantification of illicit drugs in wastewater by mixed-mode solidphase extraction and quadrupole-time-of-flight liquid chromatography-mass spectrometry. Anal Chem 2012;84:1708-17.
27. Li X, Shen B, Jiang Z, Huang Y, Zhuo X. Rapid screening of drugs of abuse in human urine by high-performance liquid chromatography coupled with high resolution and high mass accuracy hybrid linear ion trap-Orbitrap mass spectrometry. J Chromatogr A 2013;1302:95-104.
28. Wang P, Stone JA, Chen KH, Gross SF, Haller CA, Wu AHB. Incomplete recovery of prescription opioids in urine using enzymatic hydrolysis of glucuronide metabolites. J Anal Toxicol 2006;30:570-5.
29. Drees JC, Stone JA, Wu AHB. Morbidity involving the hallucinogenic designer amines MDA and 2C-I. J Forensic Sci 2009;54:1485-7.
30. Petrovic M, Barceló D. Application of liquid chromatography/quadrupole time-of-flight mass spectrometry (LC-QqTOF-MS) in the environmental analysis. J Mass Spectrom 2006;41:1259-67.
31. Zhu X, Chen Y, Subramanian R. Comparison of information-dependent acquisition, SWATH, and MSAll techniques in metabolite identification study employing ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. Anal Chem 2014;86:1202-9.